New study in European Heart Journal contradicts a recent study in the same publication, suggests evidence is lacking that digoxin increases mortality as atrial fibrillation treatment.
Study authors say manipulating hormonal signals could effectively counter age-related cognitive decline.
For the first time, UAB has unified its academic and medical brands under a common tagline in a new, broad communications campaign.
The School of Medicine rose to No. 10 in the country in primary care, 34th in research.
A UAB study is the first suggest that any drug can dramatically reduce the risk of 30-day, all-cause hospital admission among older heart failure patients.
The public debate, “High vs. Low Carbohydrate Diets for Cancer Control and Overall Health,” will take place  from 5 p.m. to 6:30 p.m. March 27 at the UAB Alumni House.

An infectious disease expert, UAB alumnus Michael Callahan, M.D., has been at the scene of some of the world's most dangerous virus outbreaks.

The University of Alabama at Birmingham has been awarded a $28 million grant renewal for the nation’s largest study aimed at exploring racial and geographic differences in stroke illness and stroke death from The National Institute for Neurological Disorders and Stroke.
Most of this disparity may be due to greater risk factor burden among blacks, including smoking, diabetes and hypertension.
Page 2 of 2